Floatz logo

Therapeutic Asset Ratings

172 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lactobacillus Rhamnosus Gg
Multiple Sclerosis
Medstar Health Research InstituteEarly P1C (34)
Liraglutide
Multiple Sclerosis
University of ChicagoEarly P1C (34)
nk042
Multiple Sclerosis
The Affiliated Hospital of Xuzhou Medical UniversityEarly P1C (34)
qt-019c
Multiple Sclerosis
Tianjin Huanhu HospitalEarly P1C (34)
SDM-8
Multiple Sclerosis
Brigham and Women's HospitalEarly P1C (34)
Ucar T-Cell
Multiple Sclerosis
Tianjin Huanhu HospitalEarly P1C (34)
Universal Bcma Car-T
Multiple Sclerosis
Xuanwu Hospital, BeijingEarly P1C (34)
Universal Cd19 Car-T
Multiple Sclerosis
Xuanwu Hospital, BeijingEarly P1C (34)
[18F] FZTA
Multiple Sclerosis
Washington University School of MedicineD (28)
Anti-T-lymphocyte globulin
Multiple Sclerosis
Ciceri FabioD (28)
Calculus Bovis Sativus
Multiple Sclerosis
Tongji HospitalN/AD (28)
CT-100 DiNaMo
Multiple Sclerosis
Click Therapeutics, Inc.N/AD (28)
EMAPUNIL
Multiple Sclerosis
Imperial College LondonN/AD (28)
Etifoxine
Multiple Sclerosis
Imperial College LondonN/AD (28)
Fuzuloparib
Multiple Sclerosis
Centre National de Rééducation Fonctionnelle et de RéadaptationN/AD (28)
GLUCAGON-LIKE PEPTIDE 1, HUMAN
Multiple Sclerosis
Northwestern UniversityD (28)
Mtm-H-001
Multiple Sclerosis
Beijing GoBroad HospitalN/AD (28)
Tamsulosin
Multiple Sclerosis
Centre Hospitalier Universitaire de NīmesN/AD (28)
Tysabri
Multiple Sclerosis
BiogenD (28)
Zeposia
Multiple Sclerosis
Corium Innovations, Inc.D (28)
Zeprumetostat
Multiple Sclerosis
Centre National de Rééducation Fonctionnelle et de RéadaptationN/AD (28)
pb018
Multiple Sclerosis
Polpharma Biologics International AGP1NR (0)
Showing 151 to 172 of 172 assets
PreviousPage 7 of 7Next